Opioids and cancer biology: Exploring the dark side of pain relief
Pathology - Research and Practice · 2026-07 · 283 · 156486
DOI: 10.1016/j.prp.2026.156486 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2026-07. Verfasst von Freshteh Haerifar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Addiction Studies, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran. Hauptthemen laut MEDLINE: Analgesics, Opioid, Cancer Pain, Neoplasms. Die Arbeit nennt 236 Literaturangaben.
Abstract (Originalsprache)
Opioids have traditionally been a fundamental component of cancer pain management; however, emerging evidence raises concerns regarding their potential influence on cancer progression. Although they are effective in alleviating the severe pain associated with malignancies, recent studies suggest that opioids may exert complex and not yet fully understood effects on tumor biology. Some research indicates that opioids could facilitate tumor growth by modulating immune suppression, promoting angiogenesis, and enhancing metastatic potential. Conversely, other investigations propose that opioids may possess anti-neoplastic properties, such as inducing apoptosis in cancer cells and enhancing immune system activity. This review aims to elucidate the multifaceted relationship between opioids and cancer, examining their dual role in symptom palliation and possible tumor progression. Additionally, it discusses the effects of opioids across different cancer types and explores alternative pain management strategies that may offer safer long-term outcomes. With ongoing advances in understanding opioids' biological impacts, it is evident that rigorously designed clinical trials are essential to clarify their role in cancer therapy and optimize their clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Addiction Studies, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
- Research Laboratory for Embryology and Stem Cell, Department of Anatomical Sciences, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
- Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran.
- Department of Medical Sciences, Student Research Committee, Islamic Azad University, Tabriz Branch, Tabriz, Iran.
- Student Research Committee, Kashan University of Medical Sciences, Kashan, Iran.
- Department of Histopathology and Anatomy, TMS.C., Islamic Azad University, Tabriz, Iran.
Zitieren
APA
Haerifar, F., Kalarestaghi, H., Mirzaei, H., Bahramloo, M., Alinejad-Shahabi, S., Samimifar, A., Ashraf Moosavi, S. S., Dizaji Asl, K., Mazloumi, Z., & Rafat, A. (2026). Opioids and cancer biology: Exploring the dark side of pain relief. Pathology - Research and Practice, 283, 156486. https://doi.org/10.1016/j.prp.2026.156486
Vancouver
Haerifar F, Kalarestaghi H, Mirzaei H, Bahramloo M, Alinejad-Shahabi S, Samimifar A, et al. Opioids and cancer biology: Exploring the dark side of pain relief. Pathology - Research and Practice. 2026;283:156486. doi:10.1016/j.prp.2026.156486
BibTeX
@article{Haerifar2026,
author = {Haerifar, Freshteh and Kalarestaghi, Hossein and Mirzaei, Hamed and Bahramloo, Mohammadmahdi and Alinejad-Shahabi, Sina and Samimifar, Arian and Ashraf Moosavi, Seyyede Sepide and Dizaji Asl, Khadijeh and Mazloumi, Zeinab and Rafat, Ali},
title = {Opioids and cancer biology: Exploring the dark side of pain relief},
journal = {Pathology - Research and Practice},
year = {2026},
volume = {283},
pages = {156486},
doi = {10.1016/j.prp.2026.156486}
}
EUVIMED